Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Revenue

Protagonist Therapeutics had revenue of $56.37M in the quarter ending March 31, 2026, with 99.03% growth. This brings the company's revenue in the last twelve months to $74.06M, down -64.36% year-over-year. In the year 2025, Protagonist Therapeutics had annual revenue of $46.02M, down -89.41%.

• Revenue (ttm): $74.06M
• Revenue Growth: -64.36%
• P/S Ratio: 87.60
• Revenue / Employee: $565,366
• Employees: 131
• Market Cap: 6.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	46.02M	-388.42M	-89.41%
Dec 31, 2024	434.43M	374.43M	624.06%
Dec 31, 2023	60.00M	33.42M	125.73%
Dec 31, 2022	26.58M	-776.00K	-2.84%
Dec 31, 2021	27.36M	-1.27M	-4.44%
Dec 31, 2020	28.63M	28.40M	12,293.07%
Dec 31, 2019	231.00K	-30.69M	-99.25%
Dec 31, 2018	30.93M	10.86M	54.14%
Dec 31, 2017	20.06M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error